Adiponectin: Novelties in Metabolism and Hormonal Regulation

References

• Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., Kuriyama, H., Nishida, M., Yamashita, S., Okubo, K., Matsubara, K., Muraguchi, M., Ohmoto, Y., Funahashi, T. and Matsuzawa, Y. (1999 ) “Paradoxical decrease of an adipose-specific protein adiponectin, in obesity”, Biochemical and Biophysical Research Communications 257, 79–83.
   PubMed Web of Science ®Google Scholar
• Bacci, S., Menzaghi, C., Ercolino, T., Ma, X., Rauseo, A., Salvemini, L., Vigna, C., Fanelli, R., Mario, U., Doria, A. and Trischitta, V. (2004 ) “The + 276g/t single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients”, Diabetes Care 27, 2015 –2020.
   PubMed Web of Science ®Google Scholar
• Bajaj, M., Suraamornkul, S., Piper, P., Hardies, L.J., Glass, L., Cersosimo, E., Pratipanawatr, T., Miyazaki, Y. and DeFronzo, R.A. (2004 ) “Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients”, Journal of Clinical Endocrinology and Metabolism 89, 200–206.
   PubMed Web of Science ®Google Scholar
• Beltowski, J. (2003) “Adiponectin and resistin-new hormones of white adipose tissue”, Medical Science Monitor 9, RA55 -RA61.
   PubMedGoogle Scholar
• Berg, A.H., Combs, T.P., Du, X., Brownlee, M. and Scherer, P.E. (2001 ) “The adipocyte-secreted protein Acrp30 enhances hepatic insulin action”, Nature Medicine 7, 947–953.
   PubMed Web of Science ®Google Scholar
• Berg, A.H., Combs, T.P. and Scherer, P.E. (2002 ) “Acrp30/adipo- nectin: an adipocytokine regulating glucose and lipid metabolism”, Trends in Endocrinology and Metabolism 13, 84–89.
   PubMed Web of Science ®Google Scholar
• Boudou, P., Sobngwi, F., Mauvais-Jarvis, Vexiau, P. and Gautier, J.-F. (2003) “Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men”, European Journal of Endocrinology 149, 421–424.
   PubMed Web of Science ®Google Scholar
• Chandran, M., Phillips, S.A., Ciaraldi, T. and Henry, R.R. (2003 ) “Adiponectin: more than just another fat cell hormone?”, Diabetes Care 26, 2442–2450.
   PubMed Web of Science ®Google Scholar
• Cnop, M., Havel, PJ., Utzschneider, K.M., Carr, D.B., Sinha, M.K., Boyko, E.J., Retzlaff, B.M., Knopp, R.H., Brunzell, J.D. and Kahn, S.E. (2003 ) “Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex”, Diabetologia 46, 459–469.
   PubMed Web of Science ®Google Scholar
• Combs, T.P., Berg, A.H., Obici, S., Scherer, P.E. and Rossetti, L. (2001 ) “Endogenous glucose production is inhibited by the adipose-derived protein Acrp30”, Journal of Clinical Investigation 12, 1875–1881.
   Google Scholar
• Combs, T.P., Wagner, J.A., Berger, J., Doebber, T., Wang, W.J., Zhang, B.B., Tanen, M., Berg, A.H., O’Rahilly, S., Savage, D.B., Chatterjee, K., Weiss, S., Larson, PJ., Gottesdiener, K.M., Gertz, B.J., Charron, M.J., Scherer, P.E. and Moller, D.E. (2002 ) “Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin senitization”, Endocrinology 143, 998–1007.
   PubMed Web of Science ®Google Scholar
• English, PJ., Coughlin, S.R., Hayden, K., Malik, I.A. and Wilding, J.P. (2003 ) “Plasma adiponectin increases postprandially in obese, but not in lean, subjects”, Obesity Research 11, 839–844.
   PubMedGoogle Scholar
• Fasshauer, M., Klein, J., Neumann, S., Ezlinger, M. and Paschke, R. (2002 ) “Hormonal regulation of adiponectin gene expression in 3T3–L1 adipocytes”, Biochemical and Biophysical Research Communications 290, 1084–1089.
   PubMed Web of Science ®Google Scholar
• Fernandez-Real, J.M., Lopez-Bermejo, A., Casamitjana, R. and Ricart, W. (2003 ) “Novel interactions of adiponectin with the endocrine system and inflammatory parameters”, Journal of Clinical Endocrinology and Metabolism 88, 2714–2718.
   PubMed Web of Science ®Google Scholar
• Fruebis, J., Tsao, T.S., Javorschi, S., Ebbets-Reed, D., Erickson, M.R., Yen, F.T., Bihain, B.E. and Lodish, H.F. (2001 ) “Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice”, Proceedings of the National Academy of Science USA 98, 2005–2010.
   PubMed Web of Science ®Google Scholar
• Gavrila, A., Peng, C.K., Chan, J.L., Mietus, J.E., Goldberger, A.L. and Mantzoros, C.S. (2003 ) “Diurnal and ultradian dynamics of serum adiponectin in health men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns”, Journal of Clinical Endocrinology and Metabolism 88, 2838–2843.
   PubMed Web of Science ®Google Scholar
• Havel, P.J. (2001 ) “Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis”, Experimental Biology and Medicine 226, 963–977.
   PubMed Web of Science ®Google Scholar
• Havel, P.J. (2002 ) “Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin”, Current Opinion in Lipidology 13, 51–59.
   PubMed Web of Science ®Google Scholar
• Hiramatsu, S., Tajiri, Y. and Karashima, T. (2004 ) “Lower plasma adiponectin concentration predicts the efficacy of piglitazone in diabetic patients”, Diabetes and Obesity Metabolism 6, 231–233.
   PubMed Web of Science ®Google Scholar
• Hirschberg, A.L. (1998 ) “Hormonal regulation of appetite and food intake”, Annals of Medicine 30, 7–20.
   PubMed Web of Science ®Google Scholar
• Hotamisligil, G.S., Arner, P., Caro, J.F., Atkinson, R.L. and Spiegelman, B.M. (1995 ) “Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance”, Journal of Clinical Investigation 95, 2409–2415.
   PubMed Web of Science ®Google Scholar
• Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, I., Wahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., Nishida, M., Kihara, S.N., Nakajima, T., Hasegawa, K., Muraguchi, M., Ohmoto, Y., Nakamura Yamashita, S., Hanafusa, T. and Matzuzawa, Y. (2000 ) “Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients”, Arteriosclerosis Thrombosis and Vascular Biology 20, 1595–1599.
   PubMed Web of Science ®Google Scholar
• Hu, E., Liang, P. and Spiegelman, B.M. (1996 ) “AdipoQ is a novel adipose-specific gene dysregulated in obesity”, Journal of Biological Chemistry 270, 26746–26749.
   Google Scholar
• Iglesias, P., Alvarez, F.P., Codoceo, R. and Diez, J.J. (2004 ) “Lipoatrophic diabetes in an elderly woman: clinical course and serum adipocytokine concentrations”, Endocrine Journal 51, 279–286.
   PubMed Web of Science ®Google Scholar
• Katsuki, A., Sumida, Y., Urakawa, H., Gabazza, E.C., Murashima, S., Kazutaka, M., Nakatani, K., Yano, Y. and Adachi, Y. (2003 ) “Plasma levels of adiponectin are associated with insulin resistance and serum levels of triglyceride in japanese metabolically obese, normal-weight men with normal glucose tolerance”, Diabetes Care 26, 2964–2965.
   PubMed Web of Science ®Google Scholar
• Kern, P.A., Di Gregorio, B.G., Lu, T., Rassouli, N. and Ranganathan, G. (2003 ) “Adiponectin expression from human adipose tissue. Relation to obesity, insulin resistance, and tumor necrosis factor-a expression”, Diabetes 52, 1779–1785.
   PubMed Web of Science ®Google Scholar
• Lee, G.A., Mafong, D.D., Noor, M.A., Lo, J.C., Mulligan, K., Schwarz, J.M., Schambelan, M. and Grunfeld, C. (2004 ) “HIV protease inhibitors increase adiponectin levels in HIV- negative men”, Journal of Acquired Immune Deficiency Syndrom 36, 645–647.
   PubMed Web of Science ®Google Scholar
• Lindsay, R.S., Funahashi, T., Hanson, R.L., Matsuzawa, Y., Tanaka, S., Tataranni, P.A., Knowler, W.C. and Krakoff, J. (2002 ) “Adiponectin and development of type 2 diabetes in the Pima Indian population”, Lancet 360, 57–58.
   PubMed Web of Science ®Google Scholar
• Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y. and Matsubara, K. (1996 ) “cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1)”, Biochemical and Biophysical Research Communications 221, 286–289.
   PubMed Web of Science ®Google Scholar
• Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N., Kuriyama, H., Hotta, K., Nakamura, T., Shimomura, I. and Matsuzawa, Y. (2001 ) “PPAR gamma ligands increase expression and plasma concentrations of adiponectin and adipose derived protein”, Diabetes 50, 2094–2099.
   PubMed Web of Science ®Google Scholar
• Mannucci, E., Ognibene, A., Cremasco, F., Dicembrini, I., Bardini, G., Brogi, M., Terreni, A., Caldini, A., Messeri, G. and Rotella, C.M. (2003 ) “Plasma adiponectin and hyperglycaemia in diabetic patients”, Clinical Chemistry and Laboratory Medicine 41, 1131–1135.
   PubMed Web of Science ®Google Scholar
• Masaki, T., Chiba, S., Yasuda, T., Tsubone, T., Kakuma, T., Shimomura, I., Funahashi, T., Matsuzawa, Y. and Yoshimatsu, H. (2003 ) “Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in Agouti Yellow (Ay/a) obese mice”, Diabetes 52, 2266–2273.
   PubMed Web of Science ®Google Scholar
• Matsubara, M., Katayose, S. and Maruoka, S. (2003 ) “Decreased plasma adiponectin concentrations in nondiabetic women with elevated homeostasis model assessment ratios”, European Journal of Endocrinology 148, 343–350.
   PubMed Web of Science ®Google Scholar
• Meier, U. and Gressner, A.M. (2004) “Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin”, Clinical Chemistry, in press.
   PubMed Web of Science ®Google Scholar
• Musi, N., Fujii, N., Hirshman, M.F., Ekberg, I., Froberg, S., Ljungquist, O., Thorell, A. and Goodyear, L.J. (2001 ) “AMP- activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise”, Diabetes 50, 921 –927.
   PubMed Web of Science ®Google Scholar
• Nakano, Y., Tobe, T., Miura, N.H.C., Mazda, T. and Tonita, T. (1996 ) “Isolation and characterization of GBP28, a novel gelatin binding protein purified by human plasma”, Journal of Biochemistry 120, 803–812.
   PubMed Web of Science ®Google Scholar
• Okamoto, Y., Arita, Y., Nishida, M., Muraguchi, M., Ouchi, N. and Takahashi, M. (2000 ) “An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls”, Hormone and Metabolic Research 32, 47–50.
   PubMed Web of Science ®Google Scholar
• Ouchi, N., Kihara, S., Arita, Y., Nishida, M., Matsuyama, A., Okamoto, Y., Ishigami, M., Kuriyama, H., Kishida, K., Nishizawa, H., Hotta, K., Muraguchi, M., Ohmoto, Y., Yamashita, S., Funahashi, T. and Matsuzawa, Y. (2001 ) “Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages”, Circulation 103, 1057–1063.
   PubMed Web of Science ®Google Scholar
• Ouchi, N., Kihara, S., Funahashi, T., Matsuzawa, Y. and Walsh, K. (2003 ) “Obesity, adiponectin and vascular inflammatory disease”, Current Opinion in Lipidology 14, 561 –566.
   PubMed Web of Science ®Google Scholar
• Rajala, M.W. and Scherer, P.E. (2003 ) “Minireview: The adipocyte- at the crossroads of energy homeostasis, inflammation, and atherosclerosis”, Endocrinology 144, 3765–3773.
   PubMed Web of Science ®Google Scholar
• Scherer, P.E., Williams, S., Fogliano, M., Baldini, G. and Lodish, H.F. (1995 ) “A novel serum protein similar to C1q, produced exclusively in adipocytes”, Journal of Biological Chemistry 270, 26746–26749.
   PubMed Web of Science ®Google Scholar
• Spranger, J., Kroke, A., Mohlig, M., Bergmann, M.M., Ristow, M., Boeing, H. and Pfeiffer, A.F. (2002 ) “Adiponectin and protection against type 2 diabetes mellitus”, Lancet 361, 226–228.
   Web of Science ®Google Scholar
• Stefan, N. and Stumvoll, M. (2002 ) “Adiponectin—its role in metabolism and beyond”, Hormone and Metabolic Research 9, 469–474.
   Google Scholar
• Stefan, N., Vozarova, B., Funahashi, T., Matsuzawa, Y., Weyer, C., Lindsay, R.S., Youngren, J.F., Pratley, R.E., Bogardus, C. and Tataranni, A. (2002 ) “Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans”, Diabetes 51, 1884–1888.
   PubMed Web of Science ®Google Scholar
• Storgaard, H., Song, X.M., Jensen, C.B., Madsbad, S., Bjornholm, M., Vaag, A. and Zierath, J.R. (2001 ) “Insulin signal transduction in skeletal muscle from glucose-intolerant relatives with type 2 diabetes”, Diabetes 50, 2770–2778.
   PubMed Web of Science ®Google Scholar
• Trayhurn, P. and Beattie, J.H. (2001 ) “Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ”, Proceedings of Nutrition Society 60, 329–339.
   PubMed Web of Science ®Google Scholar
• Tschritter, O., Fritsche, A., Thamer, C., Haap, M., Shirkavand, F., Rahe, S., Staiger, H., Maerker, E., Haering, H. and Stumvoll, M. (2003 ) “Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism”, Diabetes 52, 239–243.
   PubMed Web of Science ®Google Scholar
• Vasseur, F., Lepretre, F., Lacquemant, C. and Froguel, P. (2003 ) “The genetics of adiponectin”, Current Diabetes Reports 2, 151–158.
   Google Scholar
• Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R.E. and Tataranni, P.A. (2001 ) “Hypoadipo- nectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia”, Journal of Clinical Endocrinology and Metabolism 86, 1930–1935.
   PubMed Web of Science ®Google Scholar
• Xu, A., Yin, S., Wong, L., Chan, K.W. and Lam, K.S.L. (2004 ) “Adiponectin ameliorates dyslipidemia induced by the human immunodeficiency virus protease inhibitor ritonavir in mice”, Endocrinology 145, 487–494.
   PubMed Web of Science ®Google Scholar
• Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Reitman, M.L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., Tobe, K., Nagai, R., Kimura, S., Tomita, M., Froguel, P. and Kadowaki, T. (2001 ) “The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity”, Nature Medicine 7, 941 –946.
   PubMed Web of Science ®Google Scholar
• Yamauchi, T., Kamon, J., Waki, H., Imai, Y., Shimozawa, N., Hioki, K., Uchida, S., Ito, Y., Takakuwa, K., Matsui, J., Takata, M., Eto, K., Terauchi, Y., Komeda, K., Tsunoda, M., Murakami, K., Ohnishi, Y., Naitoh, T., Yamamura, K., Ueyama, Y., Froguel, P., Kimura, S., Nagai, R. and Kadowaki, T. (2003a ) “Globular adiponectin protected ob/ob mice from diabetes and ApoE- deficient mice from atherosclerosis”, Journal of Biological Chemistry 278, 2461 –2468.
   PubMed Web of Science ®Google Scholar
• Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., Murakami, K., Ohteki, T., Uchida, S., Takekawa, S., Waki, H. , Tsuno, N.H., Shibata, Y., Terauchi, Y., Froguel, P., Tobe, K., Koyasu, S., Taira, K., Kitamura, T., Shimizu, T., Nagai, R. and Kadowaki, T. (2003b) “Cloning of adiponectin receptors that mediate antidiabetic metabolic effects”, Nature 423, 762–769.
   PubMed Web of Science ®Google Scholar
• Yang, W.S., Lee, W.J., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C.L., Chen, C.L., Tai, T.Y. and Chuang, L.M. (2001 ) “Weight reduction increases plasma levels of an adipose- derived anti-inflammatory protein, adiponectin”, Journal of Clinical Endocrinology and Metabolism 86, 3815–3819.
   PubMed Web of Science ®Google Scholar
• Yang, X., Jansson, P.A., Nagaev, I., Jack, M.M., Carvalho, E., Sunnerhagen, K.S., Cam, M.C., Cushman, S.W. and Smith, U. (2004 ) “Evidence of impaired adipogenesis in insulin resistance”, Biochemical and Biophysical Research Communications 317, 1045–1051.
   PubMed Web of Science ®Google Scholar
• Zietz, B., Herfarth, H., Paul, G., Ehling, A., Muller-Ladner, U., Scholmerich, J. and Schaffler, A. (2003 ) “Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes”, FEBS Letters 545, 103–104.
   PubMed Web of Science ®Google Scholar